by Biospring | Nov 9, 2022 | Advisory Board, Biospring Partners
Biospring is pleased to announce the addition of two industry executives to its Advisory Board – Arnaub Chatterjee, SVP Product and Ecosystem at Medidata and Qi Wang, CIO Portfolio Implementation and Portfolio Manager at PIMCO. Biospring’s Advisors support the...
by Biospring | Apr 26, 2022 | Amazon, Biospring Partners, CIC Health, COVID-19, Health Care, Maulik Majmudar, Rodrigo Martinez, Telehealth, Vaccines
We recently hosted a discussion with Dr. Maulik Majmudar, Cardiologist and Principal Medical Officer at Amazon and Rodrigo Martinez, Chief Marketing and Experience Officer at CIC Health. Maulik and Rodrigo shared their unique perspective on how healthcare has changed...
by Biospring | Apr 26, 2022 | Astrazeneca, Biospring Partners, COVID-19, Economy, Jay Bradner, Katie Burke, Novartis, Oxford, Peter B. Henry, Return to work, Sir John Bell, Vaccines
Last December, we hosted a discussion with industry leaders on COVID-19 and Vaccines, Return-to-Work, and the Economy. We were delighted to host Dr. Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Biospring’s advisors Sir...
by Biospring | Apr 25, 2022 | Advisory Board, Biospring Partners, Drew Pearson, Growth Capital, IFE Sciences Technology, Portfolio Management, Venture Capital
Biospring Partners has appointed Drew Pearson as Head of Portfolio Management, and the firm has added several industry leaders to its Advisory Board. New York, NY and Boston, MA — December 10, 2020 — Biospring Partners, growth investors in Life Sciences Technology, is...
